South Street Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-13,730
| Closed | -$971K | – | 63 |
|
|
2017
Q2 | $971K | Sell |
13,730
-44,010
| -76% | -$3.11M | 0.32% | 39 |
|
|
2017
Q1 | $3.92K | Sell |
57,740
-3,470
| -6% | -$236 | 0.54% | 31 |
|
|
2016
Q4 | $4.38M | Sell |
61,210
-13,680
| -18% | -$980K | 1.55% | 27 |
|
|
2016
Q3 | $5.93M | Sell |
74,890
-14,118
| -16% | -$1.12M | 1.83% | 27 |
|
|
2016
Q2 | $7.43M | Sell |
89,008
-52,230
| -37% | -$4.36M | 2.34% | 24 |
|
|
2016
Q1 | $13M | Sell |
141,238
-2,299
| -2% | -$211K | 4.29% | 9 |
|
|
2015
Q4 | $14.5M | Buy |
143,537
+1,917
| +1% | +$194K | 4.64% | 3 |
|
|
2015
Q3 | $13.9M | Buy |
141,620
+2,415
| +2% | +$237K | 4.7% | 4 |
|
|
2015
Q2 | $16.3M | Buy |
139,205
+900
| +0.7% | +$105K | 5.11% | 2 |
|
|
2015
Q1 | $13.6K | Buy |
138,305
+1,240
| +0.9% | +$122 | 4.01% | 5 |
|
|
2014
Q4 | $12.9M | Buy |
137,065
+2,420
| +2% | +$228K | 4.27% | 4 |
|
|
2014
Q3 | $14.3M | Buy |
134,645
+1,540
| +1% | +$164K | 5.2% | 1 |
|
|
2014
Q2 | $11K | Buy |
133,105
+1,470
| +1% | +$122 | 3.12% | 4 |
|
|
2014
Q1 | $9.33M | Buy |
131,635
+1,580
| +1% | +$112K | 3.71% | 7 |
|
|
2013
Q4 | $9.77M | Buy |
130,055
+2,160
| +2% | +$162K | 4.08% | 5 |
|
|
2013
Q3 | $8.04M | Buy |
127,895
+121,775
| +1,990% | +$7.66M | 3.85% | 5 |
|
|
2013
Q2 | $313K | Buy |
+6,120
| New | +$313K | 0.16% | 42 |
|